doi:10.1016/j.bmcl.2006.03.079
Copyright © 2006 Elsevier Ltd All rights reserved.
Synthesis and antibacterial activity of nocathiacin I analogues
B. Narasimhulu Naidu
,
, Margaret E. Sorenson, John D. Matiskella, Wenying Li, Justin B. Sausker, Yunhui Zhang, Timothy P. Connolly, Kin S. Lam, Joanne J. Bronson, Michael J. Pucci, Hyekyung Yang and Yasutsugu Ueda
The Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT 06492, USA
Received 5 March 2006;
revised 23 March 2006;
accepted 24 March 2006.
Available online 18 April 2006.
References and further reading may be available for this article. To view references and further reading you must
purchase this article.
Abstract
Stereoselective reduction of dehydroalanine double bond in nocathiacin I afforded the primary amide 2. Enzymatic hydrolysis of the amide 2 provided the carboxylic acid 3, which upon coupling with a variety of amines furnished amides 4–32. Some of these semi-synthetic derivatives have retained very good antibacterial activity and have improved aqueous solubility.
Graphical abstract
The synthesis and antibacterial activity of nocathiacin I analogues is described.
Keywords: Nocathiacin I; Antibacterial activity
Scheme 1. Reagents and conditions: (a) catalytic [Rh(COD)(R,R-DIPAMP)]+ BF4−, H2 (60 psi), Pd/C; (b) orange peel enzyme/water/34 °C; (c) R1R2NH, EDC, PyBOP or DPPA, DMF.
Table 1.
In vitro and in vivo antibacterial activity of nocathiacin I analogues

ND means not determined.
a MICs (minimum inhibitory concentration): lowest concentration of drug that inhibits visible growth of the organism.
8b PD
50 determined by mouse systemic lethal
S. aureus infection model.
9c Equilibrium water solubility was determined with amorphous powders.
d MSSA, methicillin-sensitive
S. aureus; MSEF, methicillin-sensitive
E. faecalis.